Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 27/09/2025 | Baxter Healthcare Corporation |
U.S.A |
Baxter Oncology GmbH | 69443-406 | trastuzumab deruxtecan | 2019-05-22 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/5mL) |
| 27/09/2025 | Boehringer Ingelheim RCV GmbH & Co KG | 68594-130 | Trastuzumab deruxtecan | 2025-09-01 | 2025-12-31 | BULK INGREDIENT | POWDER, FOR SOLUTION (22g/22g) |
